Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TD8R
|
|||
| Drug Name |
3-phenyl isoquinolin-1(2H) derivative 1
|
|||
| Synonyms |
PMID27841036-Compound-20
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NERVIANO MEDICAL SCIENCES S.R.L
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H15BrClFN2O2
|
|||
| Canonical SMILES |
C1=CC(=CC=C1C2=C(C3=C(C=C(C=C3)F)C(=O)N2)OCCN)Br.Cl
|
|||
| InChI |
1S/C17H14BrFN2O2.ClH/c18-11-3-1-10(2-4-11)15-16(23-8-7-20)13-6-5-12(19)9-14(13)17(22)21-15;/h1-6,9H,7-8,20H2,(H,21,22);1H
|
|||
| InChIKey |
BSCLHAQBYMRPSH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Poly [ADP-ribose] polymerase 1 (PARP1) | Target Info | Inhibitor | [1] |
| Poly [ADP-ribose] polymerase 2 (PARP2) | Target Info | Inhibitor | [1] | |
| Poly [ADP-ribose] polymerase 3 (PARP3) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Poly [ADP-ribose] polymerase 1 (PARP1) | Target's Patent Info | [1] | |
| Poly [ADP-ribose] polymerase 2 (PARP2) | Target's Patent Info | [1] | ||
| Poly [ADP-ribose] polymerase 3 (PARP3) | Target's Patent Info | [1] | ||
| KEGG Pathway | Base excision repair | |||
| Apoptosis | ||||
| Necroptosis | ||||
| NF-kappa B signaling pathway | ||||
| Panther Pathway | FAS signaling pathway | |||
| Pathway Interaction Database | Integrin-linked kinase signaling | |||
| Caspase Cascade in Apoptosis | ||||
| Notch-mediated HES/HEY network | ||||
| Reactome | Dual Incision in GG-NER | |||
| WikiPathways | FAS pathway and Stress induction of HSP regulation | |||
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | ||||
| Nanoparticle triggered regulated necrosis | ||||
| Corticotropin-releasing hormone | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | PARP inhibitors as antitumor agents: a patent update (2013-2015).Expert Opin Ther Pat. 2017 Mar;27(3):363-382. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.